Stockscreener 앱 받기
2.36
11.85%
0.25
전일 마감가:
$2.11
열려 있는:
$2.18
하루 거래량:
1.06M
Relative Volume:
2.28
시가총액:
$220.74M
수익:
-
순이익/손실:
$1.60M
주가수익비율:
78.67
EPS:
0.03
순현금흐름:
$-62.91M
1주 성능:
+25.53%
1개월 성능:
+58.39%
6개월 성능:
+49.37%
1년 성능:
+11.32%
1일 변동 폭
$2.11
$2.38
1주일 범위
$1.8203
$2.38
52주 변동 폭
$1.13
$2.66
Compugen Ltd Stock (CGEN) Company Profile
CGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
2.36 | 197.36M | 0 | 1.60M | -62.91M | 0.03 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-07 | 개시 | H.C. Wainwright | Buy |
| 2025-01-13 | 개시 | Oppenheimer | Outperform |
| 2022-08-05 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-05-26 | 재개 | JMP Securities | Mkt Outperform |
| 2020-05-13 | 개시 | Stifel | Buy |
| 2020-05-07 | 개시 | SVB Leerink | Outperform |
| 2020-04-22 | 개시 | ROTH Capital | Buy |
| 2020-03-24 | 개시 | SunTrust | Buy |
| 2020-01-16 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-03-29 | 개시 | Oppenheimer | Outperform |
| 2016-02-01 | 재개 | Oppenheimer | Outperform |
| 2015-10-15 | 개시 | FBR Capital | Outperform |
| 2015-04-23 | 재개 | Jefferies | Buy |
| 2015-04-21 | 개시 | Oppenheimer | Outperform |
| 2014-02-07 | 개시 | MLV & Co | Buy |
| 2009-12-28 | 재확인 | Cantor Fitzgerald | Buy |
| 2009-07-29 | 개시 | Cantor Fitzgerald | Buy |
모두보기
Compugen Ltd 주식(CGEN)의 최신 뉴스
Can Compugen Ltd maintain sales growthEarnings Growth Summary & Stock Portfolio Risk Management - baoquankhu1.vn
Update Recap: Can Compugen Ltd stock continue upward trendPortfolio Value Report & Smart Money Movement Alerts - Bộ Nội Vụ
Targets Report: Will Compugen Ltd stock outperform tech sector in 2025July 2025 Volume & High Win Rate Trade Tips - Bộ Nội Vụ
Compugen shares jump after $65 million royalty monetization deal with AstraZeneca - MSN
Why Compugen Ltd. stock could benefit from AI revolutionRate Cut & Intraday High Probability Alerts - Улправда
Brokers Issue Forecasts for Compugen FY2025 Earnings - Defense World
HC Wainwright Estimates Compugen FY2025 Earnings - MarketBeat
Compugen (NASDAQ:CGEN) Coverage Initiated at HC Wainwright - Defense World
Compugen rises on royalty deal with AstraZeneca - MSN
Comparing Compugen (NASDAQ:CGEN) & Psyence Biomedical (NASDAQ:PBM) - Defense World
How buybacks impact Compugen Ltd. stock valueRate Hike & Capital Efficiency Focused Strategies - Улправда
Why Compugen Ltd. stock could rally in 2025Quarterly Portfolio Review & AI Optimized Trading Strategy Guides - Улправда
Will Compugen Ltd. stock benefit from infrastructure spending2025 Dividend Review & Low Volatility Stock Suggestions - Улправда
Is Compugen Ltd. stock a bargain at current levelsMoving Average Strategies & Expert-Backed Recommendations That Deliver - Улправда
H.C. Wainwright initiates coverage on Compugen stock with Buy rating By Investing.com - Investing.com Nigeria
Compugen (CGEN): HC Wainwright Initiates Coverage with 'Buy' Rat - GuruFocus
H.C. Wainwright initiates coverage on Compugen stock with Buy rating - Investing.com
This Applied Digital Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Benzinga
HC Wainwright & Co. Initiates Coverage of Compugen (CGEN) with Buy Recommendation - Nasdaq
Operating cash flow per share of Compugen Ltd. – TASE:CGEN - TradingView — Track All Markets
Will Compugen Ltd. stock benefit from sector rotationWeekly Profit Summary & Daily Growth Stock Tips - Улправда
Is Compugen Ltd. stock a defensive play in 2025Portfolio Gains Summary & Real-Time Volume Analysis Alerts - Улправда
Can Compugen Ltd. stock deliver strong Q4 earningsJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - Улправда
Compugen Secures $90 Million in a Strategic Royalty Monetization Deal with AstraZeneca - The Globe and Mail
Compugen (CGEN) Rises on Royalty Deal with AstraZeneca - GuruFocus
Compugen restructures AstraZeneca deal to boost cash coffers - גלובס
Compugen stock soars on $65 million AstraZeneca royalty deal By Investing.com - Investing.com Nigeria
Compugen stock soars on $65 million AstraZeneca royalty deal - Investing.com
Compugen Monetizes Portion of Cancer Treatment Future Royalties to AstraZeneca for Up to $90 Million - marketscreener.com
Compugen rises on royalty deal with AstraZeneca (CGEN:NASDAQ) - Seeking Alpha
Compugen monetizes portion of cancer drug royalties to AstraZeneca By Investing.com - Investing.com South Africa
Compugen monetizes portion of cancer drug royalties to AstraZeneca - Investing.com
Compugen monetizes portion of rilvegostomig future royalties to AstraZeneca for up to $90 million - marketscreener.com
Compugen Ltd. and Medimmune Limited Enter into Amendment Number 4 to the License Agreement - marketscreener.com
Compugen Monetizes Portion Of Rilvegostomig Future Royalties To Astrazeneca For Up To $90 Million - TradingView — Track All Markets
[6-K] COMPUGEN LTD Current Report (Foreign Issuer) | CGEN SEC FilingForm 6-K - Stock Titan
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million - marketscreener.com
Cancer immunotherapy royalty deal brings biotech up to $90M in funding - Stock Titan
Revenue per share of Compugen Ltd. – TASE:CGEN - TradingView — Track All Markets
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Compugen Presents Promising COM701 Analysis at ESMO 2025 - MSN
Compugen’s Former Head Reflects on Computational Discovery, Strategic Collaborations And AI - Citeline News & Insights
Compugen (NASDAQ:CGEN) Share Price Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat
Compugen Ltd (CGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):